How many 8-K filings has China Pharma Holdings, Inc. filed?

China Pharma Holdings, Inc. (CPHI) has 10 8-K (Current Event Report) filings on record, spanning Feb 2024 to Dec 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read China Pharma Holdings, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all China Pharma Holdings, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

China Pharma Holdings, Inc. (CPHI) — 8-K Filings

All 8-K filings from China Pharma Holdings, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

China Pharma Holdings Enters Material Agreement, Reports Equity Sales — Dec 23, 2025 Risk: medium
On December 22, 2025, China Pharma Holdings, Inc. entered into a material definitive agreement and reported unregistered sales of equity securities. The company
China Pharma Holdings Files 8-K on Agreements and Equity Sales — Dec 10, 2025 Risk: medium
China Pharma Holdings, Inc. filed an 8-K on December 10, 2025, reporting on two key events that occurred on December 4, 2025: entering into a material definitiv
China Pharma Holdings Files 8-K — Apr 4, 2025 Risk: low
On April 4, 2025, China Pharma Holdings, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits.
China Pharma Holdings Reports on Shareholder Votes — Dec 26, 2024 Risk: low
China Pharma Holdings, Inc. filed an 8-K on December 26, 2024, reporting on matters submitted to a vote of security holders as of December 22, 2024. The filing
China Pharma Holdings Enters Material Definitive Agreement — Dec 13, 2024 Risk: medium
On December 12, 2024, China Pharma Holdings, Inc. entered into a Material Definitive Agreement. The company, previously known as TS Electronics Inc. and Softsto
China Pharma Holdings Files 8-K with Material Agreement — May 30, 2024 Risk: medium
On May 23, 2024, China Pharma Holdings, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and ex
China Pharma Holdings Changes Auditors — May 8, 2024 Risk: medium
China Pharma Holdings, Inc. announced on May 7, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered publi
China Pharma Partners on Liver Disease Drug — Mar 29, 2024 Risk: medium
China Pharma Holdings, Inc. announced on March 27, 2024, that it has entered into a strategic cooperation agreement with Hainan GengSheng Pharmaceutical Co., Lt
CHINA PHARMA HOLDINGS Files 8-K on Feb 23 — Feb 23, 2024 Risk: low
CHINA PHARMA HOLDINGS, INC. filed an 8-K on February 23, 2024, disclosing information under Regulation FD and regarding financial statements and exhibits. The f
CPHI Sells Unregistered Equity Securities, Raising Capital — Feb 8, 2024 Risk: medium
CHINA PHARMA HOLDINGS, INC. (CPHI) entered into a material definitive agreement on February 2, 2024, involving the unregistered sale of equity securities. This

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX